News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
264,530 Results
Type
Article (14098)
Company Profile (282)
Press Release (250150)
Section
Business (79472)
Career Advice (152)
Deals (13221)
Drug Delivery (35)
Drug Development (50396)
Employer Resources (31)
FDA (5705)
Job Trends (5124)
News (144312)
Policy (10027)
Tag
Academia (905)
Alliances (21610)
Alzheimer's disease (796)
Antibody-drug conjugate (ADC) (75)
Approvals (5707)
Artificial intelligence (93)
Bankruptcy (102)
Best Places to Work (4560)
Biotechnology (232)
Breast cancer (130)
Cancer (1112)
Cardiovascular disease (88)
Career advice (132)
CAR-T (92)
Cell therapy (272)
Clinical research (40556)
Collaboration (436)
Compensation (184)
COVID-19 (1024)
C-suite (117)
Cystic fibrosis (74)
Data (1150)
Diabetes (105)
Diagnostics (1279)
Earnings (29211)
Events (47659)
Executive appointments (353)
FDA (6211)
Funding (414)
Gene editing (76)
Gene therapy (199)
GLP-1 (338)
Government (1072)
Healthcare (6569)
Infectious disease (1075)
Inflammatory bowel disease (105)
IPO (7248)
Job creations (859)
Job search strategy (127)
Layoffs (196)
Legal (1383)
Lung cancer (164)
Manufacturing (103)
Medical device (2580)
Medtech (2581)
Mergers & acquisitions (6207)
Metabolic disorders (315)
Neuroscience (1108)
NextGen: Class of 2025 (2014)
Non-profit (852)
Northern California (1339)
Obesity (166)
Opinion (96)
Parkinson's disease (89)
Patents (86)
People (25358)
Phase I (14314)
Phase II (18873)
Phase III (11920)
Pipeline (504)
Postmarket research (852)
Preclinical (5997)
Radiopharmaceuticals (209)
Rare diseases (248)
Real estate (1414)
Regulatory (8440)
Research institute (932)
Series A (82)
Southern California (1188)
Startups (1972)
United States (10532)
Vaccines (189)
Weight loss (96)
Date
Today (49)
Last 7 days (339)
Last 30 days (1542)
Last 365 days (20409)
2025 (2645)
2024 (20553)
2023 (22417)
2022 (26824)
2021 (27808)
2020 (23360)
2019 (16230)
2018 (11742)
2017 (13749)
2016 (11843)
2015 (14353)
2014 (10397)
2013 (7488)
2012 (7539)
2011 (7619)
2010 (7429)
Location
Africa (148)
Asia (17095)
Australia (2893)
California (3047)
Canada (965)
China (269)
Colorado (115)
Connecticut (130)
Delaware (72)
Europe (36824)
Florida (348)
Georgia (91)
Illinois (192)
Indiana (73)
Maryland (396)
Massachusetts (2385)
Minnesota (119)
New Jersey (762)
New York (835)
North Carolina (475)
Northern California (1339)
Ohio (98)
Pennsylvania (577)
South America (207)
Southern California (1188)
Texas (337)
Washington State (291)
264,530 Results for "capricor therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Capricor Therapeutics to Participate in Upcoming Investor Conferences
February 10, 2025
·
4 min read
Press Releases
Capricor Therapeutics to Present at Upcoming Investor Conferences
December 3, 2024
·
4 min read
Capricor Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes
Capricor Therapeutics announced that the Company is set to join the Russell 2000® Index and the broad-market Russell 3000® Index, effective at the open of U.S. equity markets, July 1, 2024.
July 1, 2024
·
5 min read
Biotech Beach
Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy
Capricor Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has scheduled a Pre-BLA (Biologics License Application) meeting with the Company in the third quarter of 2024 for deramiocel (CAP-1002), for the treatment of Duchenne Muscular Dystrophy (DMD).
June 25, 2024
·
5 min read
Biotech Beach
Capricor Therapeutics to Present at Upcoming Scientific and Medical Conferences
Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that the Company is scheduled to present at various upcoming scientific and medical conferences.
May 8, 2024
·
4 min read
Press Releases
Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
January 2, 2025
·
7 min read
Biotech Beach
Capricor Therapeutics to Present at Upcoming Investor Conferences
Capricor Therapeutics diseases, today announced that the Company is scheduled to present at two upcoming investor conferences.
March 21, 2024
·
4 min read
Press Releases
Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency
November 20, 2024
·
6 min read
Press Releases
Capricor Therapeutics Announces Proposed Public Offering of Common Stock
October 17, 2024
·
5 min read
Press Releases
Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 14, 2024
·
13 min read
1 of 26,453
Next
